QL
TBPH icon

Quarry LP’s Theravance Biopharma TBPH Stock Holding History

Quarry LP’s Portfolio TBPH Stock Details TBPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$493 Buy
+29
New +$480 ﹤0.01% 2165
2025
Q4 		– Sell
-1,776
Closed -$25.9K – 2601
2025
Q3 		$25.9K Buy
+1,776
New +$22.4K 0.01% 1244

Other funds holding TBPH

MAP
Madison Avenue Partners New York $2.32B AUM 132.6% 1-Year Est. Return
WAM
Weiss Asset Management Boston, Massachusetts $9.54B AUM 55.06% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
NM
Newtyn Management New York $801M AUM 23.14% 1-Year Est. Return
ICM
Irenic Capital Management New York $2.08B AUM 19.87% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

Quarry LP's TBPH Position: Q2 2026 in Review

Quarry LP opened a new position in Theravance Biopharma (TBPH) in Q2 2026: 29 shares worth $493. The stake represents ﹤0.01% of the portfolio and ranks #2165 among its holdings. This is a return to the name: Quarry LP previously reported a position in TBPH as recently as Q3 2025.

Quarry LP first reported a position in TBPH in Q3 2025 and has held it in 2 quarters since. The position peaked at $25.9K in Q3 2025. 181 funds tracked by Wall St. Rank hold TBPH as of Q2 2026.

  • Quarry LP held 29 shares of Theravance Biopharma worth $493 as of Q2 2026.
  • Theravance Biopharma was a new Quarry LP position in Q2 2026.
  • Theravance Biopharma made up ﹤0.01% of Quarry LP's portfolio in Q2 2026, its #2165 holding.
  • Quarry LP first reported a position in Theravance Biopharma in Q3 2025 and has held it in 2 quarters since.
  • Quarry LP's Theravance Biopharma position peaked at $25.9K in Q3 2025.
  • 181 funds tracked by Wall St. Rank held Theravance Biopharma as of Q2 2026.

Based on Quarry LP's 13F filing for Q2 2026, filed 14 Aug 2026.